PLAT and acute respiratory distress syndrome: The use of tPA to treat ARDS in COVID‐19 patients has recently been proposed by Moore et al.15An initial case report from three patients from the current SARS‐CoV‐2 pandemic demonstrates a transient improvement in P/F ratio in two cases and sustained 50% improvement in one case following administration of a 25 mg bolus of intravenous tPA followed by a further 25 mg infusion.83